Trending

UK biotech

Dementia, cancer headline UK’s 10-year plan for life sciences sector

Dementia, cancer headline UK’s 10-year plan for life sciences sector

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries

X

Dementia, cancer headline UK’s 10-year plan for life sciences sector

https://pharmaphorum.com/news/dementia-cancer-headline-uks-10-year-plan-for-life-sciences-sector/

Clive Dix: Rebuilding UK biotech

Clive Dix: Rebuilding UK biotech

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last

X

Clive Dix: Rebuilding UK biotech

https://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/

UK biotech investment at record levels amid COVID-19

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last

X

UK biotech investment at record levels amid COVID-19

https://pharmaphorum.com/news/uk-biotech-investment-at-record-levels-amid-covid-19/

UK cancer mutation testing firm Biofidelity raises $12m

UK cancer mutation testing firm Biofidelity raises $12m

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect

X

UK cancer mutation testing firm Biofidelity raises $12m

https://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/

GW Pharma and Orchard biggest UK biotech fundraisers in Q1

GW Pharma and Orchard biggest UK biotech fundraisers in Q1

The UK biotech sector has enjoyed a ‘solid start’ in early 2018, with GW Pharma and Orchard Therapeutics dominating the funding

X

GW Pharma and Orchard biggest UK biotech fundraisers in Q1

https://pharmaphorum.com/news/gw-pharma-orchard-biggest-uk-biotech-fundraisers-q1/

Gene sequencing upstart Oxford Nanopore raises another $140m

Gene sequencing upstart Oxford Nanopore raises another $140m

Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”

X

Gene sequencing upstart Oxford Nanopore raises another $140m

https://pharmaphorum.com/news/gene-sequencing-upstart-oxford-nanopore-raises-another-140m/

Prokarium raises $10m for ‘game changer’ synthetic bio vaccines

UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation

X

Prokarium raises $10m for ‘game changer’ synthetic bio vaccines

https://pharmaphorum.com/news/prokarium-raises-10m-game-changer-synthetic-bio-vaccines/

Acacia Pharma stock market launch to support nausea products

Acacia Pharma stock market launch to support nausea products

Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange

X

Acacia Pharma stock market launch to support nausea products

https://pharmaphorum.com/news/acacia-pharma-stock-market-launch-support-nausea-product-launch/

Boasting best pipeline in Europe, moment of truth arrives for UK biotechs in 2018

Boasting best pipeline in Europe, moment of truth arrives for UK biotechs in 2018

A new report on the UK’s bioscience sector shows it enjoyed a strong 2017, with international investment fuelling

X

Boasting best pipeline in Europe, moment of truth arrives for UK biotechs in 2018

https://pharmaphorum.com/views-and-analysis/money-flows-uk-biotech-confidence-grows/

1 2 3 4 5

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com